Egyptian Drug Authority · Egypt
DEA-EG-2026-0040
Tier 1 · Regulator-publishedUnclassifiedPublic warningStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(40) For 2026
- Date issued
- May 2026
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- Gerdustop Esomeprazole 40mg
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- Not published with the notice
- Expiry dates
- Not published with the notice
- Action type
- Public warning
- Classification
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- Gerdustop Esomeprazole 40mg 20
capsules
29281/2022رقم التسجيل المدون على
العبوات
العبور للصناعات الدوائية لصالح دايموند فارما
تداول عبوات مجهولة المصدرمن الصنف
الموضح بعاليه وذلك طبقا لقاعدة بيانات هيئة
الدواء المصرية
وقف تداول و ضبط وتحريز المستحضر
المغشوش
في حالة الشك في المستحضر الصيدلىيتم الرجوع
الى هيئة الدواء المصرية سواء بالإتصالبالخط
الساخن 15301او الموقعالإلكترونىالخاص
بالهيئة.
يمكن الضغط على الرابطللإطلاععلى الصور
الخاصة بالمستحضر الغير مطابق للمواصفات .
مايو 2026
منشور
غش تجاري
اسم المستحضر
الشركة المصنعة المدونة على
العبوات
سبب التحذير
الإجراءات
التصحيحية
نصائح
للمستهلكين
هذا التنبيه خاص بالتشغيلات الواردة في المنشور فقط ولا ينطبق على
تداول المستحضر بشكل عامOriginal language: ar
- Notice text in English
- Notice. Circulation of packs of unknown origin of Gerdustop Esomeprazole 40mg, 20 capsules, registration number printed on the packs 29281/2022, made by Obour for Pharmaceutical Industries on behalf of Diamond Pharma.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 3
Where this record came from, and what is held to show it.
- Primary source
- https://www.edaegypt.gov.eg/media/03kn2enk/1978-%D8%BA%D8%B4-%D8%AA%D8%AC%D8%A7%D8%B1%D9%8Agerdustop.pdf
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- 3912fa1e9c374667a285a6c2a43d046632ae9ad34ead8d3c16def6f801056728SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:49:44 UTC
Cite this record
Drug Eye Africa (2026). DEA-EG-2026-0040: Gerdustop Esomeprazole 40mg — Public warning, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2026/dea-eg-2026-0040Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.